TIPIC Syndrome: Beyond the Myth of Carotidynia, a New Distinct Unclassified Entity. En savoir plus sur TIPIC Syndrome: Beyond the Myth of Carotidynia, a New Distinct Unclassified Entity.
Combined brain and anterior visual pathways' MRIs assist in early identification of neuromyelitis optica spectrum disorder at onset of optic neuritis. En savoir plus sur Combined brain and anterior visual pathways' MRIs assist in early identification of neuromyelitis optica spectrum disorder at onset of optic neuritis.
Infraorbital nerve involvement on magnetic resonance imaging in European patients with IgG4-related ophthalmic disease: a specific sign. En savoir plus sur Infraorbital nerve involvement on magnetic resonance imaging in European patients with IgG4-related ophthalmic disease: a specific sign.
Dynamic susceptibility contrast perfusion imaging in biopsy-proved adult medulloblastoma. En savoir plus sur Dynamic susceptibility contrast perfusion imaging in biopsy-proved adult medulloblastoma.
Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy-Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals. En savoir plus sur Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy-Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals.
Magnetic resonance post-contrast vascular hyperintensities at 3 T: a new highly sensitive sign of vascular occlusion in acute ischaemic stroke. En savoir plus sur Magnetic resonance post-contrast vascular hyperintensities at 3 T: a new highly sensitive sign of vascular occlusion in acute ischaemic stroke.
Remote brain microhaemorrhages may predict haematoma in glioma patients treated with radiation therapy. En savoir plus sur Remote brain microhaemorrhages may predict haematoma in glioma patients treated with radiation therapy.
actionable mutations, molecular specificities, and outcome of adult midline gliomas. En savoir plus sur actionable mutations, molecular specificities, and outcome of adult midline gliomas.